Chirotech Technology Limited
Records under this name other than patents Chirotech Technology Limited holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Back to Chirotech Technology Limited
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,486,337 | Ruthenium-disphosphine complexes and their use as catalysts Term ended Term ended May 26, 2021 · From the USPTO record | Term ended | Term ended May 26, 2021 | From the USPTO record |
| US 6,414,187 | Asymmetric hydrogenation Term ended Ended no later than Dec 5, 2020 · From the USPTO record | Term ended | Ended no later than Dec 5, 2020 | From the USPTO record |
| US 6,545,183 | Process for preparing cyclic phosphines Term ended Term ended Jul 6, 2020 · From the USPTO record | Term ended | Term ended Jul 6, 2020 | From the USPTO record |
| US 6,437,152 | Intermediate for the synthesis of prostaglandins Term ended Term ended Apr 12, 2020 · From the USPTO record | Term ended | Term ended Apr 12, 2020 | From the USPTO record |
| US 6,172,249 | Chiral ligands for asymmetric catalysis Term ended Term ended Nov 4, 2019 · From the USPTO record | Term ended | Term ended Nov 4, 2019 | From the USPTO record |
| US 6,207,853 | Homogeneous asymmetric hydrogenation using phosphine ligands of transition metals Term ended Term ended Dec 17, 2018 · From the USPTO record | Term ended | Term ended Dec 17, 2018 | From the USPTO record |
| US 6,093,815 | Galanthamine derivatives and process for their preparation Formerly held Term ended Term ended Aug 20, 2018 · From the USPTO record | Term ended | Term ended Aug 20, 2018 | From the USPTO record |
| US 6,087,495 | Process for the preparation of galanthamine Formerly held Term ended Term ended Jul 2, 2018 · From the USPTO record | Term ended | Term ended Jul 2, 2018 | From the USPTO record |
| US 6,184,004 | Process for the preparation of galanthamine and its derivatives Formerly held Term ended Term ended May 26, 2018 · From the USPTO record | Term ended | Term ended May 26, 2018 | From the USPTO record |
| US 6,019,994 | Use of levobupivacaine in treating migraine Formerly held Term ended Term ended Mar 3, 2018 · From the USPTO record | Term ended | Term ended Mar 3, 2018 | From the USPTO record |